`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`Mylan Pharmaceuticals Inc.,
`Petitioner,
`
`V.
`
`Nissan Chemical Industries Ltd.,
`Patent Owner
`
`U.S. Patent No. 5,856,336
`
`Issue Date: January 5, 1999
`
`Title: Quinoline Type Mevalonolactones
`
`Inter Partes Review No. IPR2015—01069
`
`POWER OF ATTORNEY
`
`UNDER 37 C.F.R. § 42.10
`
`
`
`Pursuant to 37 C.F.R. § 42.l0(b), Patent Owner Nissan Chemical Industries,
`
`Ltd. hereby appoints the practitioners associated with Mintz Levin Cohn Ferris
`
`Glovsky and Popeo, P.C. as its attorneys to transact all business before the Patent
`
`Trial and Appeal Board of the United States Patent & Trademark Office in
`
`connection with all inter partes review proceedings involving U.S. Patent No.
`
`5,856,336. Lead and backup counsel are separately designated in Patent Owner’s
`
`Mandatory Notice.
`
`The undersigned is authorized to sign on behalf of Patent Owner
`
` g2
`
`For: Nissan Chemical Industries, Ltd., Patent Owner
`
`Name: Takuya Kakuta
`
`Senior Managing Associate Executive Officer
`
`Title: Head of Intellectual Proper_ty Department
`
`/V/Q/E 5)! GL0/3?‘
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner’s Power of Attorney was served on May 8th, 2015 by sending a copy by
`
`overnight courier to:
`
`Jitendra Malik
`
`4721 Emperor Blvd., Suite 400
`Durham, North Carolina 27703
`
`Deanne M. Mazzochi
`
`Rakoczy Molino Mazzochi Siwik LLP
`6 West Hubbard St., Suite 500
`
`Chicago, Illinois 60654
`
`/Kathleen B. Carr/
`
`Kathleen B. Carr
`
`Reg. No. 41,658